
Another promising approach for hard-to-treat blood cancers
For patients with some hard-to-treat blood cancers, a new “off-the-shelf” immunotherapy is achieving promising results.…
For patients with some hard-to-treat blood cancers, a new “off-the-shelf” immunotherapy is achieving promising results.…
New research published today in the journal Blood Advances is the first to show that restricting calories,…
For certain blood cancers, such as acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS), deciding…
A new substance could improve the treatment of persistent cancers. Researchers at Martin Luther University…
Researchers from University of Utah, USA, report significant new insights into the development of blood…
Using advanced RNA sequencing, scientists have identified two unique subtypes of a prominent mutation present…
Pioneering research into how our bodies manufacture the cells that make blood has moved us…
Patients with acute myeloid leukaemia (AML), the most common form of acute leukaemia in adults,…
Myelodysplastic Syndromes (MDS) and acute myeloid leukaemia (AML) are rare haematologic malignancies of the bone…
The largest ever clinical trial looking at the best way to treat lymphoma if it…